https://feeds.newsfilecorp.com/company/10824 Latest news from Purisys, as distributed by TMX Newsfile. en CopyRight (c) 2026, Newsfile Corp. All Rights Reserved. office@newsfilecorp.com (Newsfile Corp.) office@newsfilecorp.com (Newsfile Corp.) Tue, 10 Mar 2026 06:22:17 -0400 https://www.newsfilecorp.com/images/newswire/customer-logos/10824.jpg https://feeds.newsfilecorp.com/company/10824 https://www.newsfilecorp.com/release/222751/Purisys-Activates-Drug-Master-File-for-Nalmefene-Introducing-New-Solution-for-Acute-Opioid-Overdose-Treatment Athens, Georgia--(Newsfile Corp. - September 10, 2024) - Purisys LLC, a leading supplier of active pharmaceutical ingredients (APIs), contract development and manufacturing (CDMO) services, and pharmaceutical reference materials, has submitted its new commercial Drug Master File (DMF) with the US Food and Drug Administration for the active pharmaceutical ingredient nalmefene hydrochloride. The DMF number for nalmefene hydrochloride is 39767 and it is now available for reference, allowing...<img src="https://api.newsfilecorp.com/newsinfo/222751/156" id="156" width="2" height="2" style="width: 1px; height: 1px;border: 0px solid;" /> Tue, 10 Sep 2024 09:00:00 -0400 en https://www.newsfilecorp.com/release/222751